Exclusion of the Left Atrial Appendage to Prevent Stroke in Cases of Atrial Fibrillation

作者: Armin Barekatain , Ali Massumi , Abdi Rasekh

DOI:

关键词:

摘要: Atrial fibrillation (AF) is the most common cardiac arrhythmia.1 The risk of stroke attributable to AF rises dramatically with age: 1.5% for persons aged 50 59 years, and that increases 9.9% 70 79 23.5% 80 89.2 left atrial appendage (LAA) has an anatomic structure very favorable thrombus formation in patients AF, who often experience limited contraction stagnant blood flow. In fact, a review published reports reveals 90% cardiothrombic events non-rheumatic originate from LAA.2 All these studies, except one which autopsy was performed, used transesophageal echocardiography (TEE) detection thrombi.2

参考文章(13)
Anne S. Kanderian, A. Marc Gillinov, Gosta B. Pettersson, Eugene Blackstone, Allan L. Klein, Success of Surgical Left Atrial Appendage Closure: Assessment by Transesophageal Echocardiography Journal of the American College of Cardiology. ,vol. 52, pp. 924- 929 ,(2008) , 10.1016/J.JACC.2008.03.067
Valentin Fuster, Lars E. Rydén, Davis S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, G. Neal Kay, Jean-Yves Le Huezey, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo, L. Samuel Wann, 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Journal of the American College of Cardiology. ,vol. 57, pp. e101- e198 ,(2011) , 10.1016/J.JACC.2010.09.013
Christopher R.C. Wyndham, Atrial fibrillation: the most common arrhythmia. Texas Heart Institute Journal. ,vol. 27, pp. 257- 267 ,(2000)
Robert G. Hart, Lesly A. Pearce, Maria I. Aguilar, Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation Annals of Internal Medicine. ,vol. 146, pp. 857- 867 ,(2007) , 10.7326/0003-4819-146-12-200706190-00007
Alan S. Go, Elaine M. Hylek, Leila H. Borowsky, Kathleen A. Phillips, Joe V. Selby, Daniel E. Singer, Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Annals of Internal Medicine. ,vol. 131, pp. 927- 934 ,(1999) , 10.7326/0003-4819-131-12-199912210-00004
Rebecca Brown Fountain, David R. Holmes, Krishnaswamy Chandrasekaran, Douglas Packer, Samuel Asirvatham, Robert Van Tassel, Zoltan Turi, The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. American Heart Journal. ,vol. 151, pp. 956- 961 ,(2006) , 10.1016/J.AHJ.2006.02.005
Ri-Bo Tang, Jian-Zeng Dong, Xing-Peng Liu, De-Yong Long, Rong-Hui Yu, Xin Du, Xiao-Hui Liu, Chang-Sheng Ma, Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation? Thrombosis and Haemostasis. ,vol. 105, pp. 1107- 1109 ,(2011) , 10.1160/TH10-12-0800
William H. Maisel, Left atrial appendage occlusion--closure or just the beginning? The New England Journal of Medicine. ,vol. 360, pp. 2601- 2603 ,(2009) , 10.1056/NEJMP0903763
Krzysztof Bartus, Jacek Bednarek, Jacek Myc, Boguslaw Kapelak, Jerzy Sadowski, Jacek Lelakowski, Steven J. Yakubov, Randall J. Lee, Feasibility of closed-chest ligation of the left atrial appendage in humans Heart Rhythm. ,vol. 8, pp. 188- 193 ,(2011) , 10.1016/J.HRTHM.2010.10.040
P A Wolf, R D Abbott, W B Kannel, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. ,vol. 22, pp. 983- 988 ,(1991) , 10.1161/01.STR.22.8.983